{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:09:37Z","timestamp":1789229377990,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jphs.2025.01.003","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T23:59:00Z","timestamp":1736035140000},"page":"104-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Goreisan suppresses cardiac remodeling and dysfunction in a new mouse model with diabetic cardiomyopathy"],"prefix":"10.1016","volume":"157","author":[{"given":"Masafumi","family":"Funamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuho","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Du Ly-Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Imanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuka","family":"Ebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Ohminami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumasa","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2025.01.003_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8208237","article-title":"Effects of highly absorbable curcumin in patients with impaired glucose tolerance and non-insulin-dependent diabetes mellitus","volume":"2019","author":"Funamoto","year":"2019","journal-title":"J Diabetes Res"},{"issue":"4","key":"10.1016\/j.jphs.2025.01.003_bib2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ Res"},{"issue":"11","key":"10.1016\/j.jphs.2025.01.003_bib3","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","article-title":"Basic mechanisms of diabetic heart disease","volume":"126","author":"Ritchie","year":"2020","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.jphs.2025.01.003_bib4","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","article-title":"Molecular mechanisms of diabetic cardiomyopathy","volume":"57","author":"Bugger","year":"2014","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.jphs.2025.01.003_bib5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.molmed.2013.01.005","article-title":"Breaking down protein degradation mechanisms in cardiac muscle","volume":"19","author":"Lyon","year":"2013","journal-title":"Trends Mol Med"},{"issue":"9","key":"10.1016\/j.jphs.2025.01.003_bib6","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.amjmed.2008.03.046","article-title":"Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options","volume":"121","author":"Aneja","year":"2008","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.jphs.2025.01.003_bib7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","article-title":"Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling","volume":"35","author":"Cohn","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jphs.2025.01.003_bib8","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/CIRCRESAHA.118.314665","article-title":"Diabetic cardiomyopathy","volume":"124","author":"Dillmann","year":"2019","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.jphs.2025.01.003_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.anl.2023.04.009","article-title":"Reviewing Kampo medicine (traditional Japanese herbal medicine) for otology\/neurotology diseases","volume":"51","author":"Okayasu","year":"2024","journal-title":"Auris Nasus Larynx"},{"issue":"2","key":"10.1016\/j.jphs.2025.01.003_bib10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1254\/fpj.143.65","article-title":"[Effect of Goreisan on the urinary concentrating ability and the expressions of aquaporins in 5\/6 nephrectomized rats]","volume":"143","author":"Jo","year":"2014","journal-title":"Nihon Yakurigaku Zasshi"},{"key":"10.1016\/j.jphs.2025.01.003_bib11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ahj.2023.02.013","article-title":"Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: a randomized clinical trial","volume":"260","author":"Yaku","year":"2023","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.jphs.2025.01.003_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jphs.2023.07.001","article-title":"TJ-17 (Goreisan) mitigates renal fibrosis in a mouse model of folic acid-induced chronic kidney disease","volume":"153","author":"Suenaga","year":"2023","journal-title":"J Pharmacol Sci"},{"issue":"6","key":"10.1016\/j.jphs.2025.01.003_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14061269","article-title":"Pyrazole-curcumin suppresses cardiomyocyte hypertrophy by disrupting the CDK9\/CyclinT1 complex","volume":"14","author":"Funamoto","year":"2022","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.jphs.2025.01.003_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041771","article-title":"Histone acetylation domains are differentially induced during development of heart failure in dahl salt-sensitive rats","volume":"22","author":"Funamoto","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"9-10","key":"10.1016\/j.jphs.2025.01.003_bib15","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1242\/dmm.001941","article-title":"Rodent models of diabetic cardiomyopathy","volume":"2","author":"Bugger","year":"2009","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.jphs.2025.01.003_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115843","article-title":"The current state of preclinical modeling of human diabetic cardiomyopathy using rodents","volume":"168","author":"Jasi\u0144ska-Stroschein","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jphs.2025.01.003_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/817616","article-title":"Effect of Japanese herbal Kampo medicine goreisan on reoperation rates after burr-hole surgery for chronic subdural hematoma: analysis of a national inpatient database","volume":"2015","author":"Yasunaga","year":"2015","journal-title":"Evid Based Complement Alternat Med."},{"issue":"1","key":"10.1016\/j.jphs.2025.01.003_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/tkm2.1276","article-title":"Goreisan regulates AQP3 expression and improves diarrhea","volume":"8","author":"Murakami Ih","year":"2021","journal-title":"Traditional & Kampo Medicine"},{"issue":"2","key":"10.1016\/j.jphs.2025.01.003_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jphs.2023.12.001","article-title":"Goreisan regulates cerebral blood flow according to barometric pressure fluctuations in female C57BL\/6J mice","volume":"154","author":"Kurauchi","year":"2024","journal-title":"J Pharmacol Sci"},{"issue":"2-3","key":"10.1016\/j.jphs.2025.01.003_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/micc.12788","article-title":"Impact of Goreisan components on rat mesenteric collecting lymphatic vessel pumping","volume":"30","author":"Jo","year":"2023","journal-title":"Microcirculation"},{"issue":"4","key":"10.1016\/j.jphs.2025.01.003_bib21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jacc.2005.09.050","article-title":"The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy","volume":"47","author":"Asbun","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jphs.2025.01.003_bib22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.freeradbiomed.2021.03.046","article-title":"Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy","volume":"169","author":"Byrne","year":"2021","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"10.1016\/j.jphs.2025.01.003_bib23","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2337\/diabetes.51.6.1938","article-title":"Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway","volume":"51","author":"Cai","year":"2002","journal-title":"Diabetes"},{"issue":"16","key":"10.1016\/j.jphs.2025.01.003_bib24","doi-asserted-by":"crossref","first-page":"E2048","DOI":"10.1073\/pnas.1415111112","article-title":"Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-beta signaling","volume":"112","author":"Oruqaj","year":"2015","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"3","key":"10.1016\/j.jphs.2025.01.003_bib25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/jmcc.1994.1036","article-title":"Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms","volume":"26","author":"Weber","year":"1994","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jphs.2025.01.003_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.746382","article-title":"Left ventricular hypertrophy in diabetic cardiomyopathy: a target for intervention","volume":"8","author":"Mohan","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jphs.2025.01.003_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/srep39604","article-title":"Serelaxin treatment reverses vascular dysfunction and left ventricular hypertrophy in a mouse model of Type 1 diabetes","volume":"7","author":"Ng","year":"2017","journal-title":"Sci Rep"},{"issue":"5 Pt B","key":"10.1016\/j.jphs.2025.01.003_bib28","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.bbadis.2017.07.025","article-title":"The role of NADPH oxidases in diabetic cardiomyopathy","volume":"1864","author":"Hansen","year":"2018","journal-title":"Biochim Biophys Acta, Mol Basis Dis"},{"issue":"2","key":"10.1016\/j.jphs.2025.01.003_bib29","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/cphy.c160021","article-title":"Pathophysiological fundamentals of diabetic cardiomyopathy","volume":"7","author":"Hu","year":"2017","journal-title":"Compr Physiol"},{"issue":"6","key":"10.1016\/j.jphs.2025.01.003_bib30","first-page":"4529","article-title":"Research progress on the PI3K\/AKT signaling pathway in gynecological cancer (Review)","volume":"19","author":"Shi","year":"2019","journal-title":"Mol Med Rep"},{"issue":"18","key":"10.1016\/j.jphs.2025.01.003_bib31","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.2174\/138161211796390976","article-title":"Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failure","volume":"17","author":"Aoyagi","year":"2011","journal-title":"Curr Pharmaceut Des"},{"issue":"6","key":"10.1016\/j.jphs.2025.01.003_bib32","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1161\/01.RES.0000261924.76669.36","article-title":"Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy","volume":"100","author":"Matsui","year":"2007","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.jphs.2025.01.003_bib33","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/01.CIR.101.6.660","article-title":"Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart","volume":"101","author":"Fujio","year":"2000","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.jphs.2025.01.003_bib34","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1161\/01.CIR.100.23.2373","article-title":"Adenoviral gene transfer of activated phosphatidylinositol 3'-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro","volume":"100","author":"Matsui","year":"1999","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.jphs.2025.01.003_bib35","doi-asserted-by":"crossref","first-page":"12355","DOI":"10.1111\/jcmm.15725","article-title":"Curcumin alleviates oxidative stress and inhibits apoptosis in diabetic cardiomyopathy via Sirt1-Foxo1 and PI3K-Akt signalling pathways","volume":"24","author":"Ren","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jphs.2025.01.003_bib36","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1472-6882-14-242","article-title":"Oryeongsan inhibits LPS-induced production of inflammatory mediators via blockade of the NF-kappaB, MAPK pathways and leads to HO-1 induction in macrophage cells","volume":"14","author":"Oh","year":"2014","journal-title":"BMC Compl Alternative Med"},{"issue":"1","key":"10.1016\/j.jphs.2025.01.003_bib37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2169\/internalmedicine.3030-19","article-title":"Oryeongsan (goreisan) ameliorates experimental autoimmune encephalomyelitis","volume":"59","author":"Inada","year":"2020","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.jphs.2025.01.003_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/tkm2.1275","article-title":"Goreisan inhibits vascular endothelial cell migration and angiogenesis","volume":"8","author":"Murakami","year":"2021","journal-title":"Traditional & Kampo Medicine"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861325000039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861325000039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T01:32:48Z","timestamp":1740533568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861325000039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1347861325000039"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2025.01.003","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Goreisan suppresses cardiac remodeling and dysfunction in a new mouse model with diabetic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2025.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}